ArticleOncology reviews2025
Research on the application of a multi-model cascaded deep learning framework in the pathological diagnosis of osteosarcoma.
Article in Oncology reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Deep learning-based quantitative histopathology of endoscopic biopsies in Crohn's disease: a retrospective cross-sectional validation study.Frontiers in immunology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Osteosarcoma is the most common malignant tumor of bone tissue in adolescents, and precise pathological diagnosis is the primary foundation for establishing the most effective treatment plan. The pathological evaluation of tumor necrosis after chemotherapy is crucial for assessing therapeutic efficacy in osteosarcoma patients. However, pathologists often face several challenges during the diagnosis and evaluation process. Methods: To address these needs, we designed and developed a multi-model cascaded deep learning framework utilizing an advanced Vision Mamba (ViM) model as the core network architecture. The study employed one of the most comprehensive osteosarcoma datasets, sourced from: (1) real-world data from 68 osteosarcoma patients collected at Chongqing General Hospital, and (2) publicly available osteosarcoma assessment data from the University of Texas Southwestern/UT Dallas. Pathological images were annotated using the Palgo pathology image artificial intelligence self-training platform according to algorithm requirements. A triple verification mechanism of annotation, review, and archiving was implemented, and Palgo's integrated interactive algorithm correction mechanism was used to continuously refine the data annotation process. Results and Discussion: The model demonstrated Dice coefficient values of 0.83 or higher in tumor segmentation, osteosarcoma osteoid matrix segmentation, necrotic area segmentation, lung metastatic tumor segmentation, and lung metastatic osteoid matrix segmentation. For necrosis classification, overall osteosarcoma subtypes, and localized osteosarcoma subtypes, the area under the receiver operating characteristics curve (AUC), sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) all exceeded 90%. The proposed model exhibited excellent performance, indicating high potential for future clinical application in osteosarcoma patients. This framework shows promise for enhancing the precision and efficiency of pathological diagnosis and evaluation in osteosarcoma management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.